Literature DB >> 25747973

Soluble CD163 as a prognostic biomarker in B-cell chronic lymphocytic leukemia.

Line Nederby1, Anne S Roug1,2, Signe S Knudsen3, Anni Skovbo4, Eigil Kjeldsen1, Holger J Moller5, Marianne Hokland4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25747973     DOI： 10.3109/10428194.2015.1026899

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  6 in total

1.  CD163-positive cancer cells are potentially associated with high malignant potential in clear cell renal cell carcinoma.

Authors:  Chaoya Ma; Hasita Horlad; Koji Ohnishi; Takenobu Nakagawa; Sohsuke Yamada; Shohei Kitada; Takanobu Motoshima; Tomomi Kamba; Toshiyuki Nakayama; Naohiro Fujimoto; Motohiro Takeya; Yoshihiro Komohara
Journal:  Med Mol Morphol       Date:  2017-07-07       Impact factor: 2.309

2.  Is sCD163 a Clinical Significant Prognostic Value in Cancers? A Systematic Review and Meta-Analysis.

Authors:  Shushu Qian; Hong Zhang; Huibo Dai; Bangyun Ma; Fang Tian; PengJun Jiang; Haoran Gao; Xiaocao Sha; Xuemei Sun
Journal:  Front Oncol       Date:  2020-11-10       Impact factor: 6.244

3.  Preoperative serum macrophage activated biomarkers soluble mannose receptor (sMR) and soluble haemoglobin scavenger receptor (sCD163), as novel markers for the diagnosis and prognosis of gastric cancer.

Authors:  Dongbing Ding; Yang Song; Yao Yao; Songbai Zhang
Journal:  Oncol Lett       Date:  2017-07-08       Impact factor: 2.967

4.  Soluble Levels of CD163, PD-L1, and IL-10 in Renal Cell Carcinoma Patients.

Authors:  Sabina Davidsson; Sofia Huotilainen; Jessica Carlsson; Pernilla Sundqvist
Journal:  Diagnostics (Basel)       Date:  2022-01-28

5.  Nurse-like cells impact on disease progression in chronic lymphocytic leukemia.

Authors:  F Boissard; C Laurent; A G Ramsay; A Quillet-Mary; J-J Fournié; M Poupot; L Ysebaert
Journal:  Blood Cancer J       Date:  2016-01-15       Impact factor: 11.037

6.  Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma.

Authors:  Heli Vajavaara; Frida Ekeblad; Harald Holte; Judit Jorgensen; Suvi-Katri Leivonen; Mattias Berglund; Peter Kamper; Holger J Moller; Francesco D'Amore; Daniel Molin; Gunilla Enblad; Maja Ludvigsen; Ingrid Glimelius; Sirpa Leppa
Journal:  Haematologica       Date:  2021-09-01       Impact factor: 9.941
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.